Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMA ADMA Biologics, Inc. daily Stock Chart
ADMA [NASD]
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-1.34 Insider Own7.90% Shs Outstand59.38M Perf Week-4.42%
Market Cap230.99M Forward P/E- EPS next Y-0.58 Insider Trans-27.03% Shs Float46.48M Perf Month7.16%
Income-61.00M PEG- EPS next Q-0.29 Inst Own51.90% Short Float9.22% Perf Quarter-15.80%
Sales16.50M P/S14.00 EPS this Y23.90% Inst Trans21.11% Short Ratio4.49 Perf Half Y15.77%
Book/sh0.22 P/B17.68 EPS next Y44.40% ROA-62.40% Target Price11.94 Perf Year-15.62%
Cash/sh0.28 P/C14.00 EPS next 5Y- ROE-205.40% 52W Range2.08 - 6.96 Perf YTD62.76%
Dividend- P/FCF- EPS past 5Y9.40% ROI- 52W High-44.11% Beta2.72
Dividend %- Quick Ratio2.40 Sales past 5Y40.80% Gross Margin- 52W Low87.02% ATR0.20
Employees318 Current Ratio4.60 Sales Q/Q-12.50% Oper. Margin- RSI (14)48.72 Volatility3.80% 5.45%
OptionableYes Debt/Eq5.74 EPS Q/Q28.30% Profit Margin- Rel Volume0.58 Prev Close3.89
ShortableYes LT Debt/Eq5.72 EarningsAug 07 AMC Payout- Avg Volume954.18K Price3.89
Recom1.70 SMA201.70% SMA50-4.45% SMA200-9.15% Volume553,212 Change0.00%
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Jul-08-19 08:22AM  ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB® GlobeNewswire +5.01%
Jun-27-19 09:30AM  Did ADMA Biologics, Inc. (NASDAQ:ADMA) Insiders Buy Up More Shares? Simply Wall St.
09:28AM  How Many ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Did Insiders Buy, In The Last Year? Simply Wall St.
Jun-18-19 04:35PM  ADMA Biologics: Selloff Creates Buying Opportunity GuruFocus.com
Jun-06-19 07:25AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ADMA Biologics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -12.53%
May-30-19 06:14PM  ADMA Biologics Is De-Risked and Ready to Rise GuruFocus.com
May-29-19 07:11AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
May-24-19 10:30AM  These 3 Biotech Stocks Are Attracting Insider Buying TheStreet.com
May-21-19 04:20PM  ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
09:15AM  Adma Biologics Inc (ADMA) President and CEO Adam S Grossman Bought $120,000 of Shares GuruFocus.com
May-16-19 08:00AM  NeuBase Therapeutics Designates Industry Leaders to Board of Directors GlobeNewswire -5.17%
May-15-19 04:35PM  ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock GlobeNewswire
May-10-19 06:58AM  FDA Approves Prior Approval Supplement for BIVIGAM® GlobeNewswire
May-08-19 07:03PM  Adma Biologics: 1Q Earnings Snapshot Associated Press
04:18PM  ADMA Biologics Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-17-19 07:08AM  ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections GlobeNewswire
Apr-03-19 08:19AM  The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings Benzinga
Apr-02-19 06:58PM  ADMA Receives Department of Health and Human Services U.S. License GlobeNewswire +24.32%
10:26AM  ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy Benzinga
09:00AM  ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment MarketWatch
07:30AM  The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
Apr-01-19 08:09PM  FDA Approves ASCENIV, a Novel Intravenous Immune Globulin GlobeNewswire +7.39%
Mar-13-19 08:19PM  Adma Biologics: 4Q Earnings Snapshot Associated Press
05:05PM  ADMA Biologics Reports Full Year 2018 Financial Results GlobeNewswire
Feb-25-19 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Feb-12-19 12:30PM  Watch These Tech Stocks Set The Pace On Tuesday 2/12/19 ACCESSWIRE +20.83%
07:38AM  ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors GlobeNewswire
Jan-07-19 07:08AM  ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAM® Complete Response Letter GlobeNewswire +6.44%
Dec-26-18 11:40AM  Have Insiders Been Buying ADMA Biologics, Inc. (NASDAQ:ADMA) Shares This Year? Simply Wall St. -9.21%
Dec-23-18 07:25AM  Here is What Hedge Funds Think About ADMA Biologics Inc (ADMA) Insider Monkey
Dec-20-18 06:20PM  Here's Why ADMA Biologics Is Getting Hammered Today Motley Fool -45.61%
06:08AM  ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAM® PAS Submissions GlobeNewswire
Dec-19-18 06:36PM  FDA declines to approve re-launch of ADMA Biologics' Bivigam Reuters
06:10PM  FDA declines to approve re-launch of ADMA Biologics' Bivigam Reuters
05:58PM  ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions GlobeNewswire
09:18AM  ADMA Biologics Provides Regulatory Update for BIVIGAM® GlobeNewswire
Dec-17-18 06:30AM  ADMA Biologics Upcoming PDUFA Dates and Milestones ACCESSWIRE
Dec-16-18 02:18PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Nov-13-18 08:10AM  Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-08-18 05:27PM  Adma Biologics: 3Q Earnings Snapshot Associated Press
05:05PM  ADMA Biologics Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-30-18 10:00AM  ADMA: Bivigam Delay But Will Recoup Sales Later Zacks Small Cap Research +6.56%
Oct-17-18 07:08AM  ADMA Biologics Receives PDUFA Date for RI-002 GlobeNewswire
Oct-11-18 08:48AM  ADMA Biologics Provides Regulatory Update for BIVIGAM® GlobeNewswire
Oct-03-18 07:08AM  ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center GlobeNewswire
Oct-01-18 07:08AM  ADMA Biologics Resubmits Biologics License Application for RI-002 GlobeNewswire -5.80%
Sep-05-18 07:08AM  ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved GlobeNewswire +6.04%
Aug-31-18 02:44PM  Penny Stocks to Watch for September 2018 Investopedia
Aug-27-18 09:15AM  ADMA: FDA Submissions are Next Milestones Zacks Small Cap Research
07:28AM  ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference GlobeNewswire
Aug-10-18 07:18AM  Adma Biologics: 2Q Earnings Snapshot Associated Press
07:08AM  ADMA Biologics Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-30-18 10:30AM  ADMA: Inspection Concluded; Product Filings Can Begin Zacks Small Cap Research
Jul-27-18 08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga
Jul-26-18 03:39PM  Here's Why ADMA Biologics Rose as Much as 27.3% Today Motley Fool +21.46%
10:50AM  ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection GlobeNewswire
07:58AM  ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission GlobeNewswire
Jun-25-18 07:08AM  ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes GlobeNewswire
Jun-13-18 07:48AM  Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111 Benzinga
Jun-12-18 04:05PM  ADMA Biologics Announces Closing of $40M Public Offering GlobeNewswire
Jun-08-18 09:08AM  ADMA Biologics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-07-18 04:05PM  ADMA Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-04-18 10:00AM  ADMA: Biotest Share Retirement Good for Shareholders Zacks Small Cap Research -7.98%
May-18-18 09:47AM  Who Owns Most Of ADMA Biologics Inc (NASDAQ:ADMA)? Simply Wall St.
07:30AM  Blog Exposure - ADMA Biologics Received US Patent for Treating Respiratory Infections ACCESSWIRE
May-16-18 07:30AM  ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections GlobeNewswire
May-14-18 05:28PM  Adma Biologics: 1Q Earnings Snapshot Associated Press +5.41%
05:05PM  ADMA Biologics Reports First Quarter 2018 Financial Results GlobeNewswire
01:17PM  ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest GlobeNewswire
May-08-18 01:55PM  Will ADMA Biologics Incs (NASDAQ:ADMA) Earnings Grow In The Next Couple Of Years? Simply Wall St.
Apr-24-18 07:28AM  ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership GlobeNewswire
Mar-19-18 06:30PM  ADMA Biologics Inc (NASDAQ:ADMA): Should The Recent Earnings Drop Worry You? Simply Wall St. +5.75%
Mar-12-18 03:50PM  When Will ADMA Biologics Inc (NASDAQ:ADMA) Turn A Profit? Simply Wall St.
Mar-05-18 07:00AM  ADMA Biologics Reports Full Year 2017 Financial Results GlobeNewswire
Feb-27-18 07:08AM  ADMA Biologics to Present at Raymond James 39th Annual Institutional Investors Conference GlobeNewswire
Jan-29-18 04:32PM  Does ADMA Biologics Incs (NASDAQ:ADMA) CEO Salary Compared Well With Others? Simply Wall St.
Dec-15-17 10:55AM  Does ADMA Biologics Incs (NASDAQ:ADMA) Past Performance Indicate A Weaker Future? Simply Wall St. +6.05%
Dec-13-17 07:50AM  Wired News ADMA Files Biologics License Application for Its Third Plasma Collection Center ACCESSWIRE
Dec-11-17 07:08AM  ADMA Files Biologics License Application For Its Third Plasma Collection Center GlobeNewswire -5.43%
Nov-29-17 10:46AM  ETFs with exposure to ADMA Biologics, Inc. : November 29, 2017 Capital Cube
Nov-27-17 10:10AM  ADMA Biologics Inc (ADMA): What Does It Mean For Your Portfolio? Simply Wall St.
Nov-15-17 08:08AM  ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions GlobeNewswire +11.27%
Nov-13-17 05:00PM  ADMA: Third Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research +6.90%
12:30PM  ADMA Biologics Announces Closing of $42M Follow-On Offering GlobeNewswire
Nov-10-17 03:35PM  Are ADMA Biologics Incs (ADMA) Interest Costs Too High? Simply Wall St.
Nov-09-17 08:58AM  ADMA Biologics Announces Pricing of Follow-On Offering GlobeNewswire +11.11%
Nov-08-17 02:29PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017 Capital Cube
Nov-07-17 09:34AM  ETFs with exposure to ADMA Biologics, Inc. : November 7, 2017 Capital Cube +8.74%
Nov-03-17 05:08PM  Adma Biologics posts 3Q profit Associated Press
05:02PM  ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-27-17 04:11PM  Why ADMA Biologics Inc (ADMA) Could Be A Buy Simply Wall St.
Oct-25-17 09:45AM  ETFs with exposure to ADMA Biologics, Inc. : October 25, 2017 Capital Cube
Oct-11-17 07:11AM  Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing GlobeNewswire
Sep-28-17 10:08AM  ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017 Capital Cube -10.70%
Sep-07-17 12:03PM  ETFs with exposure to ADMA Biologics, Inc. : September 7, 2017 Capital Cube
Sep-05-17 11:53AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
Aug-28-17 09:00AM  ADMA: Second Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research
Aug-23-17 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 09:25PM  Adma Biologics reports 2Q loss Associated Press
04:15PM  ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results GlobeNewswire
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trials for the treatment of primary immune deficiency disease. The company also offers Nabi-HB, a hyperimmune globulin for the treatment of acute exposure; and Bivigam, an intravenous immune globulin for the treatment of primary humoral immunodeficiency. In addition, it operates source plasma collection facilities in Norcross, Marietta, and Kennesaw, Georgia. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Biotest Divestiture Trust10% OwnerJun 06Sale3.755,813,95421,802,3284,295,580Jun 07 04:25 PM
PERCEPTIVE ADVISORS LLC10% OwnerMay 21Buy4.004,000,00016,000,00011,521,102May 23 08:32 AM
Guiheen Lawrence P.DirectorMay 17Buy4.0025,000100,00050,000May 21 07:13 AM
Grossman Jerrold BDirectorMay 17Buy4.0012,00048,000110,007May 21 07:14 AM
Mond JamesEVP, CSO and CMOMay 17Buy4.004,50018,00017,889May 21 07:12 AM
Grossman Adam SPresident and CEOMay 17Buy4.0025,000100,000821,301May 21 07:11 AM
Grossman Adam SPresident and CEOMay 17Buy4.005,00020,00037,527May 21 07:11 AM
LENZ BRIANEVP, CFOMay 17Buy4.005,00020,00025,000May 21 07:12 AM